Proximal tubule reabsorptive dysfunction linked to increased cardiovascular death risk in community adults

While chronic kidney disease (CKD) is a known cardiovascular disease (CVD) risk factor, traditional markers like eGFR and albuminuria primarily reflect glomerular health, overlooking crucial tubule function. Proximal tubule reabsorptive dysfunction, characterized by impaired handling of low molecular weight proteins, contributes to tubulointerstitial inflammation, fibrosis, and CKD progression. Existing evidence linking this dysfunction to CVD largely comes from cohorts with pre-existing kidney or cardiovascular conditions, leaving its association in the general population, independent of other CKD risk factors, largely unexplored.

Researchers conducted a population-based cohort study using data from the HUNT-3 cohort to evaluate the association between proximal tubule reabsorptive dysfunction and cardiovascular death. They measured urinary levels of low molecular weight proteins, specifically alpha-1-microglobulin (A1M) and beta-2-microglobulin (B2M), as biomarkers for proximal tubule health. The study aimed to assess how these biomarkers, reflecting tubule function, correlate with the risk of cardiovascular death among community-living adults, independent of established CKD risk factors, eGFR, and albuminuria.

The provided abstract outlines the study's objective to investigate the association of urinary biomarkers A1M and B2M with the risk of cardiovascular death within a general population-based cohort. While specific quantitative results (e.g., hazard ratios, p-values, or percentages) are not detailed in the provided text, the study's design implies an intention to demonstrate a statistically significant link. The authors previously showed that impaired proximal tubule dysfunction is associated with major adverse kidney events, independent of CKD risk factors, eGFR, and albuminuria. This current work extends that inquiry to cardiovascular outcomes. The core hypothesis is that:

Proximal tubule reabsorptive dysfunction, as measured by urinary A1M and B2M, will be independently associated with an increased risk for cardiovascular death in community-living adults.